Newswise — December 8, 2021, VANCOUVER, Canada--- A new study published in Alzheimer’s Research & Therapy finds that a simple, self-administered test, Self-Administered Gerocognitive Examination (SAGE ...
The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.
Re “New Potential for Diagnosing Alzheimer’s Disease” (Science Times, July 21): Blood-based detection of Alzheimer’s would do more than change how the disease is diagnosed. It could catch the disease ...
On August 24, 2026, the U.S. FDA cleared a new single-biomarker blood test to help doctors detect signs of Alzheimer’s disease. The test helps doctors determine both rule-in (positive result) and rule ...
The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results